NCT03984734

Brief Summary

This was a randomized unblinded single-centre trial. The main hypothesis of the study was that pylorus-preserving pancreatoduodenectomy reduces the incidence of delayed gastric emptying . Patients undergoing pancreatoduodenectomy were randomized to undergo one of two types of surgical technique: pylorus-preserving pancreatoduodenectomy versus stardard pancreatoduodenectomy with antrectomy. The primary endpoint was the incidence and severity of delayed gastric emptying. Secondary endpoints were postoperative morbidity and mortality, length of hospital stay, and nutritional status and quality of life.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2003

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2003

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2008

Completed
10.7 years until next milestone

First Submitted

Initial submission to the registry

March 25, 2019

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 13, 2019

Completed
Last Updated

June 13, 2019

Status Verified

June 1, 2019

Enrollment Period

5 years

First QC Date

March 25, 2019

Last Update Submit

June 11, 2019

Conditions

Keywords

Delayed Gastric EmptyingPylorus-preserving pancreatoduodenectomy

Outcome Measures

Primary Outcomes (1)

  • Incidence and severity of DGE

    Nasogastric tube not removed before the 10th postoperative days or if liquids were not tolerated before the 14th postoperative day

    within the first 90 days after surgery

Secondary Outcomes (3)

  • Postoperative morbidity

    within the first 90 days after surgery

  • Postoperative mortality

    within the first 90 days after surgery

  • Length of hospital stay

    within the first 90 days after surgery

Study Arms (2)

Control group

ACTIVE COMPARATOR

Patients undergoing pancreatoduodenectomy with antrectomy

Procedure: Pancreatoduodenectomy with antrectomy

Study group

EXPERIMENTAL

Patients undergoing pancreatoduodenectomy with pylorus-preserving pancreatoduodenectomy

Procedure: Pylorus-preserving pancreatoduodenectomy

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who underwent surgical resection of the head of the pancreas at the authors' institution from August 2003 to August 2008. Adults of either sex aged over 18 years were included.

You may not qualify if:

  • Associated resections of other organs, except for the portal or superior mesenteric vein
  • Total pancreatectomy
  • Previous gastrectomy or other gastric surgeries
  • Neoadjuvant treatment
  • Liver cirrhosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Busquets J, Martin S, Secanella L, Sorribas M, Cornella N, Altet J, Pelaez N, Bajen M, Carnaval T, Videla S, Fabregat J. Delayed gastric emptying after classical Whipple or pylorus-preserving pancreatoduodenectomy: a randomized clinical trial (QUANUPAD). Langenbecks Arch Surg. 2022 Sep;407(6):2247-2258. doi: 10.1007/s00423-022-02583-9. Epub 2022 Jul 4.

MeSH Terms

Conditions

Gastroparesis

Interventions

Pancreaticoduodenectomy

Condition Hierarchy (Ancestors)

Stomach DiseasesGastrointestinal DiseasesDigestive System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Digestive System Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Juan Fabregat Prous, Dr.

    Hospital Universitari de Bellvitge

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff surgeon Bellvitge Universitary Hospital

Study Record Dates

First Submitted

March 25, 2019

First Posted

June 13, 2019

Study Start

August 1, 2003

Primary Completion

August 1, 2008

Study Completion

August 1, 2008

Last Updated

June 13, 2019

Record last verified: 2019-06